Navigation Links
CytImmune To Present At ASCO Phase I Clinical Trial of CYT-6091 to,be Presented on June 3, 2007

ROCKVILLE, Md., April 4, 2007 -- CytImmune, a clinical stage nanomedicine company focused on the development and commercialization of multifunctional, tumor-targeted therapies has been selected to present a poster abstract at the 43rd American Society of Clinical Oncology Annual Meeting in Chicago Illinois, June 1-5. The poster session will take place from 8:00 am to 12 noon on June 3. Dr. Lawrence Tamarkin, CEO of CytImmune will present the poster abstract entitled "Preliminary Results of a Phase I clinical trial of CYT-6091: A pegylated colloidal gold TNF nanomedicine.


"Acceptance to ASCO provides CytImmune the opportunity to present its research to the leading body of international oncology experts," said Dr. Lawrence Tamarkin, CEO of CytImmune Sciences. "For an emerging company, it's a chance interact with those in the field, advance science and demonstrate our role in the fight against cancer."


CYT-6091 (Aurimune), CytImmune's lead drug compound, is recombinant human tumor necrosis factor alpha (TNF) bound to the surface of 27 nanometer pegylated colloidal gold nanoparticles. While TNF's tumor killing properties are well documented, its clinical use has been severely limited due to unacceptable toxicities. To harness the potential of this anti-cancer agent, CytImmune's approach simultaneously binds PEG-Thiol and TNF to the surface of colloidal gold nanoparticles, whose design is to: (1) make them invisible to immune detection, thereby avoiding uptake by the liver and spleen and (2) target delivery of TNF directly to tumor sites. At 27 nanometers in size, CYT-6091 is able to exit the blood stream through leaky blood vessels and sequester in and around tumor sites with TNF binding to available receptors in this area. Preclinical studies indicate that CYT-6091 is then able to actively and passively target tumors, potentially delivering more drug to the site of disease with reduced side effects. The mechanism of targeting solid tumor
'"/>




Page: 1 2

Related medicine technology :

1. CytImmune Presents Positive CYT-6019 Data During the American Society of Clinical Oncology Annual Meeting in Chicago
2. The Past, Present and Future of HLA Typing
3. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
8. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
9. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
11. Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: CytImmune Present ASCO Phase Clinical Trial CYT Presented June
(Date:11/29/2009)...wswire/ -- At the 95th Scientific Assembly an...rth America (RSNA) from November 29 to December 3 ...e will introduce its comprehensive portfolio for i... East Building/Lakeside Center, Hall D . Using ... therapy, the interventional radiologist navigat...
(Date:11/29/2009)...ire/ -- FUJIFILM Medical Systems USA, Inc. is plea...at panel DR cassette, at the 2009 Radiological Soc...l for any clinical environment, FDR D-EVO uses an ...th Fujifilm,s trademark image quality and outstand...users to transition to DR without modification to ...
(Date:11/29/2009)...ire/ -- Researchers using functional magnetic reso...e found that men and women respond differently to ...y presented today at the annual meeting of the Rad...Men may direct more attention to sensory aspects o...rms of implications for required action, whereas w...
Breaking Medicine Technology:Minimally Invasive Procedure for Oncology 2Minimally Invasive Procedure for Oncology 3Minimally Invasive Procedure for Oncology 4Minimally Invasive Procedure for Oncology 5FUJIFILM's DR Cassette Makes World Debut 2New Study Finds Men and Women May Respond Differently to Danger 2New Study Finds Men and Women May Respond Differently to Danger 3New national study finds increase in P E class related injuries 53440 1New national study finds increase in P E class related injuries 53440 2Millions Of U S Children Low In Vitamin D 53438 1Millions Of U S Children Low In Vitamin D 53438 2HIV integrase inhibitor effective for patients beginning antiretroviral treatment 53437 1HIV integrase inhibitor effective for patients beginning antiretroviral treatment 53437 2
(Date:11/29/2009)...urope show a steady decline in mortality between t...l cancers in the European Union (EU) between these... percent in women, with a large drop among the mid...ine in the cancer journal, Annals of Oncology [1...at there was an average 185.2 deaths per 100,000 o...
(Date:11/29/2009)...e/ -- The following is an investment opinion relea... ,, Intellivest Securities Research, Inc., ("IS...ublished a Report on BioClinica, Inc. ( BIOC) whic...ology and medical device industries. A primary se... submit medical imaging portions of their submissi...
(Date:11/29/2009)...doctors-in-training how to do ultrasound-guided pr...ls without compromising patient care and safety, a..., The study shows that this simulation-based tra...ical residents, knowledge, dexterity and confidenc...d-guided procedures, including breast biopsies, li...
(Date:11/29/2009)...PRNewswire/ -- Acuo Technologies, developers of hi...data migration tools and services, today announced...ws image sharing across the networks of hospitals,...ution is based on the versatile Acuo Technologies ...are enables secure access from various PACS to med...
(Date:11/29/2009)...ent equals a $41,000 pay raise, researchers say ,...Psychological therapy may be much more effective a...ing a lottery prize, suggests an English study. ,...e who provided information about their mental well...om a $1,329 course of therapy was so significant t...
Breaking Medicine News(10 mins):Health News:New figures on cancer in Europe show a steady decline in mortality but big variations 2Health News:New figures on cancer in Europe show a steady decline in mortality but big variations 3Health News:New figures on cancer in Europe show a steady decline in mortality but big variations 4Health News:New figures on cancer in Europe show a steady decline in mortality but big variations 5Health News:Research Report on BioClinica, Inc. as Speculative Buy 2Health News:Simulated training for ultrasound-guided procedures improves safety without risk to patients 2Health News:Acuo Technologies Announces a New Offering That Enables Sharing of Imaging Studies Securely and Affordably 2Health News:Psychotherapy Can Boost Happiness More Than Money: Study 2
...-positive Libyan children have stated that each ch...n) in compensation. // The lawyers had made ...g six foreign medics who have been accused of deli...hat had begun in May that the lawyers have started...
...operly for their safety and efficacy, says a new s.... // The drugs that are being indiscriminately pre...ations and sedatives. The researchers analyz...end the period of time that a company holds exclus...
...d from Rajasthan, officials say. According to the ...re treating// 20 patients with symptoms of dengue....the maximum number of cases have been reported fro...ntrol the disease. Dengue is a mosquito-bor...
...ganization has suggested that doctors are still cl...inst SARS// in the event of the return of the drea...ted during and after the 2003 outbreak that killed... harm than good, says the paper, published today i...
... may be losing a part of their brain along with th...e September 12, 2006, issue of Neurology, the scie...y. The study, which looked at 120 people ov...density in their brains even though they weren’t d...
...he first case of bird flu has been reported in a p...//. The fatal virus was confirmed on Sept.6 an...he National Task Force on Bird Flu Sam Okware. ...on bird flu to enhance surveillance and public edu...
Other Medicine News:Health News:Libyan Lawyers For The HIV-positive Children Seek 15million Dinars As Compensation 2Health News:Doctors Unaware If Pediatric Dosages Are Safe 2Health News:Doctors Unaware If Pediatric Dosages Are Safe 3Health News:Treatment of SARS Still a Mystery 2Health News:Forgetful? You May Be Losing More Than Just Your Memory 2
pH 7.01 Buffer Solution
...Slimline single-use pH catheters are efficient, ec...n and allow greater patient comfort during the tes...ms have been designed to use temperature correctio...calibration. The temperature correction factors fo...
Sensors
Anti-Human (Umana) Eu-tTG IgG Assay
Medicine Products: